Pharmaceutically acceptable salts and crystalline forms of GLP-1 receptor agonists and methods for preparing same

JP2024547113APending Publication Date: 2024-12-26JIANGSU HENGRUI MEDICINE CO LTD +1

Patent Information

Application Number
JP2024537986
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-23
Filing Date
2022-12-23
Publication Date
2024-12-26

Smart Images

  • Figure 2024547113000026
    Figure 2024547113000026
  • Figure 2024547113000027
    Figure 2024547113000027
  • Figure 2024547113000028
    Figure 2024547113000028
Patent Text Reader

Abstract

The present invention provides a pharma- ceutically acceptable salt of a GLP-1 receptor agonist, a crystalline form thereof, and a method for preparing the same. Specifically, the present invention provides a pharma- ceutically acceptable salt of the compound 2-((4-((S)-3-(4-chloro-2-fluorophenyl)-2,3-dihydrobenzo[b][1,4]dioxan-5-yl)piperidin-1-yl)methyl)-1-(((S)-oxetan-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid and a crystalline form thereof.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • GLP-1 receptor agonists and uses thereof

    JP2021521265A

  • Crystalline forms of GLP-1 receptor agonists and methods for preparing same

    JP2024547112A

  • Fused imidazole derivatives, their preparation method and their pharmaceutical applications

    JP7812052B2

  • GLP-1r agonists and uses thereof

    WO2020103815A1

  • Methyl-substituted benzobisoxazole compound and use thereof

    WO2021249492A1

Cited By

  • Crystalline forms of GLP-1 receptor agonists and methods for preparing same

    JP2024547112A